Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clarithromycin or sulfamethoxazole/trimethoprim prophylaxis in newly diagnosed multiple myeloma
2012-004424-38Phase 3Completed
- Sponsor
- Aalborg University Hospital
- Start
- Apr 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in multiple myeloma (MM) and bacterial disease comparing Clarithromycin + standard therapy, Sulfamethoxazole/trimethoprim + standard therapy and Observation + standard therapy (3 arms). Primary endpoint: Frequency of infections. Started Apr 2013; status: completed.
02
Drugs
clarithromycinsulfamethoxazoletrimethoprim
03
Conditions
multiple myeloma (MM)bacterial disease
Beyond the preview
Go deeper on 2012-004424-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-004424-38.